Revelation Biosciences (REVB) Competitors $2.38 -0.17 (-6.67%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.44 +0.06 (+2.48%) As of 08/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock REVB vs. GELS, ALLR, CTXR, ATHA, TRIB, ABP, CYCC, MRKR, NEUP, and BTAIShould you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include Gelteq (GELS), Allarity Therapeutics (ALLR), Citius Pharmaceuticals (CTXR), Athira Pharma (ATHA), Trinity Biotech (TRIB), Abpro (ABP), Cyclacel Pharmaceuticals (CYCC), Marker Therapeutics (MRKR), Neuphoria Therapeutics (NEUP), and BioXcel Therapeutics (BTAI). These companies are all part of the "pharmaceutical products" industry. Revelation Biosciences vs. Its Competitors Gelteq Allarity Therapeutics Citius Pharmaceuticals Athira Pharma Trinity Biotech Abpro Cyclacel Pharmaceuticals Marker Therapeutics Neuphoria Therapeutics BioXcel Therapeutics Gelteq (NASDAQ:GELS) and Revelation Biosciences (NASDAQ:REVB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Which has better earnings and valuation, GELS or REVB? Gelteq has higher revenue and earnings than Revelation Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGelteq$100K156.70-$2.33MN/AN/ARevelation BiosciencesN/AN/A-$15.04M-$68.61-0.03 Is GELS or REVB more profitable? Gelteq's return on equity of 0.00% beat Revelation Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets GelteqN/A N/A N/A Revelation Biosciences N/A -247.38%-146.49% Does the media favor GELS or REVB? In the previous week, Revelation Biosciences had 2 more articles in the media than Gelteq. MarketBeat recorded 2 mentions for Revelation Biosciences and 0 mentions for Gelteq. Gelteq's average media sentiment score of 0.00 beat Revelation Biosciences' score of -1.50 indicating that Gelteq is being referred to more favorably in the media. Company Overall Sentiment Gelteq Neutral Revelation Biosciences Very Negative Do insiders & institutionals have more ownership in GELS or REVB? 12.8% of Revelation Biosciences shares are held by institutional investors. 2.3% of Revelation Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryGelteq beats Revelation Biosciences on 5 of the 8 factors compared between the two stocks. Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding REVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart REVB vs. The Competition Export to ExcelMetricRevelation BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.65M$2.99B$5.50B$9.72BDividend YieldN/A2.28%4.59%4.12%P/E Ratio-0.0317.1130.0524.70Price / SalesN/A330.47456.53100.55Price / CashN/A40.7324.8428.01Price / Book0.098.888.525.76Net Income-$15.04M-$54.75M$3.27B$267.05M7 Day Performance-2.46%0.01%6.13%5.08%1 Month Performance-15.90%0.64%0.07%0.61%1 Year Performance-95.04%8.71%36.43%22.83% Revelation Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)REVBRevelation Biosciences0.2706 of 5 stars$2.38-6.7%N/A-95.0%$3.65MN/A-0.0310News CoverageNegative NewsEarnings ReportGap DownGELSGelteqN/A$1.67flatN/AN/A$15.77M$100K0.00N/AGap UpALLRAllarity Therapeutics2.4108 of 5 stars$1.02+0.5%$9.00+786.7%-78.2%$15.31MN/A0.0010Upcoming EarningsCTXRCitius Pharmaceuticals1.8908 of 5 stars$1.42+1.8%$53.00+3,645.6%-93.7%$15.10MN/A0.0020News CoverageUpcoming EarningsATHAAthira Pharma3.6397 of 5 stars$0.38+2.6%$11.25+2,852.8%-87.0%$14.87MN/A-0.1840News CoverageEarnings ReportGap UpTRIBTrinity Biotech0.9433 of 5 stars$0.82+0.0%N/A-64.6%$14.80M$61.56M-0.28480News CoverageUpcoming EarningsABPAbproN/A$0.24+0.9%$4.00+1,557.7%N/A$14.67M$180K0.0015Positive NewsHigh Trading VolumeCYCCCyclacel Pharmaceuticals0.523 of 5 stars$9.08-7.4%N/A-97.4%$14.60M$14K-0.0114Upcoming EarningsMRKRMarker Therapeutics3.9651 of 5 stars$1.26+1.6%$13.17+945.0%-68.7%$14.25M$6.59M-0.9560Upcoming EarningsGap UpNEUPNeuphoria Therapeutics1.132 of 5 stars$7.55-3.0%$21.00+178.1%N/A$14.19M$10K0.00N/ABTAIBioXcel Therapeutics4.071 of 5 stars$2.38-6.4%$42.60+1,692.2%-65.5%$13.91M$2.27M-0.1790News CoverageUpcoming EarningsGap Up Related Companies and Tools Related Companies Gelteq Competitors Allarity Therapeutics Competitors Citius Pharmaceuticals Competitors Athira Pharma Competitors Trinity Biotech Competitors Abpro Competitors Cyclacel Pharmaceuticals Competitors Marker Therapeutics Competitors Neuphoria Therapeutics Competitors BioXcel Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:REVB) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REVB Stock Alerts